ARTHUR A LEVIN, a director at $RNA ($RNA), sold 1,872 shares of the company on 01-21-2025 for an estimated $53,536. We received data on the trade from a recent SEC filing. This was a sale of approximately 12.6% of their shares of this class of stock. Following this trade, they now own 12,958 shares of this class of $RNA stock.
$RNA Insider Trading Activity
$RNA insiders have traded $RNA stock on the open market 42 times in the past 6 months. Of those trades, 0 have been purchases and 42 have been sales.
Here’s a breakdown of recent trading of $RNA stock by insiders over the last 6 months:
- W. MICHAEL FLANAGAN (Chief Scientific Officer) has made 0 purchases and 10 sales selling 241,308 shares for an estimated $10,011,836.
- MICHAEL F MACLEAN (Chief Financial Officer) has made 0 purchases and 7 sales selling 132,267 shares for an estimated $5,808,596.
- TERESA MCCARTHY (Chief Human Resources Officer) has made 0 purchases and 8 sales selling 127,263 shares for an estimated $5,110,717.
- SARAH BOYCE (President and CEO) has made 0 purchases and 5 sales selling 103,132 shares for an estimated $3,998,221.
- TAMAR THOMPSON sold 30,000 shares for an estimated $1,349,259
- ARTHUR A LEVIN has made 0 purchases and 5 sales selling 20,195 shares for an estimated $881,281.
- KATHLEEN P. GALLAGHER (Chief Program Officer) has made 0 purchases and 4 sales selling 9,411 shares for an estimated $277,912.
- STEVEN GEORGE HUGHES (Chief Medical Officer) has made 0 purchases and 2 sales selling 3,947 shares for an estimated $112,856.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RNA Hedge Fund Activity
We have seen 150 institutional investors add shares of $RNA stock to their portfolio, and 86 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- COWEN AND COMPANY, LLC removed 5,129,103 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $235,579,700
- VANGUARD GROUP INC added 3,283,202 shares (+55.2%) to their portfolio in Q3 2024, for an estimated $150,797,467
- WELLINGTON MANAGEMENT GROUP LLP added 3,228,923 shares (+84.9%) to their portfolio in Q3 2024, for an estimated $148,304,433
- STATE STREET CORP added 1,386,087 shares (+41.7%) to their portfolio in Q3 2024, for an estimated $63,662,975
- JANUS HENDERSON GROUP PLC added 1,239,323 shares (+33.9%) to their portfolio in Q3 2024, for an estimated $56,922,105
- BANK OF AMERICA CORP /DE/ added 1,151,748 shares (+602.2%) to their portfolio in Q3 2024, for an estimated $52,899,785
- BLACKROCK, INC. added 1,104,406 shares (+12.8%) to their portfolio in Q3 2024, for an estimated $50,725,367
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
